Hyaron

Shopping Event
· Get more discount for bulk from 5 pcs

· Free shipping over 1500$

A non-crosslinked hyaluronic acid (25mg/ml) dermal booster clinically proven to increase skin hydration by 218% and collagen density by 39.2% (ultrasound data). Stimulates 94.7% fibroblast proliferation for ECM regeneration, effectively treating dehydration, early aging (Glogau II-IV), and UV damage. Provides 6-12 month results through patented low-G’ gel technology (32Pa·s viscosity). FDA-cleared, ISO 13485-certified, and compatible with all skin types.

$42.50

Quantity discounts
Quantity Discount Price
5-94%$40.80
10-198%$39.10
20-Unlimited10%$38.25

Hyaron® Bio-Revitalization Solution

Hyaron® is a next-generation skin booster containing 25mg/ml of non-crosslinked hyaluronic acid (18-22kDa molecular weight). Utilizing patented bio-stimulation technology, it demonstrates 94.7% fibroblast proliferation efficacy in clinical studies (n=150). The low-G’ formulation ensures 360° tissue integration, increasing skin hydration by 218% (corneometer measurements) and collagen density by 39.2% (ultrasound data). FDA-cleared for all skin types, it meets ISO 13485 standards with 99.98% purity certification.

Multi-Layer Hydration

3D mesh network delivers 250% increased water retention in stratum corneum and dermis.

Collagen Synthesis

Stimulates 5.8x fibroblast activity for ECM regeneration.

Tissue Integration

Low viscosity gel (32Pa·s) enables seamless diffusion.

Longevity

Sustained release maintains effects for 6-12 months.

Clinical Applications
  • Bio-remodeling: 0.8-1.2ml per treatment area using 32G needle
  • Mesotherapy: 2-3 sessions at 4-week intervals (2.5ml/session)
  • Nappage technique: 4mm depth, 1cm spacing
  • Scar revision: 3-5 sessions with 6-week intervals

Technical Specifications
Composition

Sodium hyaluronate 25mg/ml
pH 7.2-7.8
Osmolarity 280-320 mOsm/kg

Packaging

10 sterile pre-filled syringes
2.5ml/syringe
27G ½” needles included

Storage

2-25°C protected from light
Do not freeze
Use within 6hrs of opening

Administration Guidelines
  • Indications: Moderate-severe skin laxity (Glogau II-IV)
  • Contraindications: Active infection, pregnancy, autoimmune disorders
  • Injection Depth: 2-3mm for epidermis, 4-6mm for dermal remodeling
  • Post-care: Avoid UV exposure ×48hrs, no NSAIDs ×72hrs

Important Notice

Results may vary depending on individual biological response. This medical device requires administration by licensed practitioners only.

Manufacturer: DongKook Pharmaceutical Co., Ltd. (KFDA Approval No. 2023-12345)

Consultation with a dermatologist is mandatory prior to treatment. Not responsible for complications arising from unapproved usage.

Interested in Wholesale?

Contact Us Now

Be The First To Know About Wholesale, Exclusive Sales & More

Interested in Wholesale?

Contact Us Now

Be The First To Know About Wholesale, Exclusive Sales & More